nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—SLC8A1—epilepsy syndrome	0.386	0.587	CbGaD
Icosapent—TRPV1—epilepsy syndrome	0.239	0.363	CbGaD
Icosapent—PTGS2—epilepsy syndrome	0.0334	0.0508	CbGaD
Icosapent—TRPV1—spinal nerve—epilepsy syndrome	0.0155	0.174	CbGeAlD
Icosapent—PTGS1—Diazepam—epilepsy syndrome	0.00931	0.559	CbGbCtD
Icosapent—TRPV1—vagus nerve—epilepsy syndrome	0.00766	0.0859	CbGeAlD
Icosapent—PTGS1—Valproic Acid—epilepsy syndrome	0.00734	0.441	CbGbCtD
Icosapent—FABP7—telencephalic ventricle—epilepsy syndrome	0.00523	0.0587	CbGeAlD
Icosapent—FABP7—ganglion—epilepsy syndrome	0.00325	0.0365	CbGeAlD
Icosapent—TRPV1—ganglion—epilepsy syndrome	0.00295	0.0331	CbGeAlD
Icosapent—Alpha-Linolenic Acid—SLC8A1—epilepsy syndrome	0.00252	0.578	CrCbGaD
Icosapent—FABP7—hindbrain—epilepsy syndrome	0.00247	0.0277	CbGeAlD
Icosapent—ACSL3—forebrain—epilepsy syndrome	0.00224	0.0251	CbGeAlD
Icosapent—PPARG—forelimb—epilepsy syndrome	0.00223	0.025	CbGeAlD
Icosapent—ACSL3—telencephalon—epilepsy syndrome	0.00206	0.0231	CbGeAlD
Icosapent—SLC8A1—forebrain—epilepsy syndrome	0.00186	0.0208	CbGeAlD
Icosapent—SLC8A1—telencephalon—epilepsy syndrome	0.00171	0.0192	CbGeAlD
Icosapent—Alpha-Linolenic Acid—TRPV1—epilepsy syndrome	0.00156	0.357	CrCbGaD
Icosapent—FABP7—brainstem—epilepsy syndrome	0.00141	0.0159	CbGeAlD
Icosapent—Oropharyngeal pain—Levetiracetam—epilepsy syndrome	0.00138	0.0149	CcSEcCtD
Icosapent—FABP7—forebrain—epilepsy syndrome	0.00137	0.0153	CbGeAlD
Icosapent—ACSL3—head—epilepsy syndrome	0.00128	0.0144	CbGeAlD
Icosapent—FABP7—telencephalon—epilepsy syndrome	0.00126	0.0141	CbGeAlD
Icosapent—ACSL3—nervous system—epilepsy syndrome	0.00122	0.0136	CbGeAlD
Icosapent—ACSL3—central nervous system—epilepsy syndrome	0.00117	0.0131	CbGeAlD
Icosapent—FADS1—telencephalon—epilepsy syndrome	0.00114	0.0128	CbGeAlD
Icosapent—ACSL4—forebrain—epilepsy syndrome	0.00112	0.0126	CbGeAlD
Icosapent—PPARD—forebrain—epilepsy syndrome	0.00108	0.0121	CbGeAlD
Icosapent—SLC8A1—head—epilepsy syndrome	0.00106	0.0119	CbGeAlD
Icosapent—Eructation—Oxcarbazepine—epilepsy syndrome	0.00103	0.0111	CcSEcCtD
Icosapent—SLC8A1—nervous system—epilepsy syndrome	0.00101	0.0113	CbGeAlD
Icosapent—PPARD—telencephalon—epilepsy syndrome	0.000993	0.0111	CbGeAlD
Icosapent—Malnutrition—Primidone—epilepsy syndrome	0.000981	0.0106	CcSEcCtD
Icosapent—SLC8A1—central nervous system—epilepsy syndrome	0.00097	0.0109	CbGeAlD
Icosapent—Eructation—Lamotrigine—epilepsy syndrome	0.000952	0.0103	CcSEcCtD
Icosapent—ACSL3—brain—epilepsy syndrome	0.00093	0.0104	CbGeAlD
Icosapent—FADS1—medulla oblongata—epilepsy syndrome	0.000895	0.01	CbGeAlD
Icosapent—FABP7—spinal cord—epilepsy syndrome	0.00088	0.00987	CbGeAlD
Icosapent—Arthralgia—Primidone—epilepsy syndrome	0.000835	0.00905	CcSEcCtD
Icosapent—FADS1—midbrain—epilepsy syndrome	0.000818	0.00918	CbGeAlD
Icosapent—ACSL4—medulla oblongata—epilepsy syndrome	0.000813	0.00912	CbGeAlD
Icosapent—FADS1—spinal cord—epilepsy syndrome	0.000798	0.00895	CbGeAlD
Icosapent—TRPV1—spinal cord—epilepsy syndrome	0.000798	0.00895	CbGeAlD
Icosapent—FABP7—head—epilepsy syndrome	0.000782	0.00877	CbGeAlD
Icosapent—SLC8A1—brain—epilepsy syndrome	0.00077	0.00864	CbGeAlD
Icosapent—Eructation—Valproic Acid—epilepsy syndrome	0.000757	0.0082	CcSEcCtD
Icosapent—Malnutrition—Rufinamide—epilepsy syndrome	0.00075	0.00813	CcSEcCtD
Icosapent—ACSL4—midbrain—epilepsy syndrome	0.000743	0.00833	CbGeAlD
Icosapent—FABP7—nervous system—epilepsy syndrome	0.000741	0.00832	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Felbamate—epilepsy syndrome	0.000733	0.00794	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Primidone—epilepsy syndrome	0.000729	0.0079	CcSEcCtD
Icosapent—ACSL4—spinal cord—epilepsy syndrome	0.000725	0.00813	CbGeAlD
Icosapent—Alanine aminotransferase increased—Felbamate—epilepsy syndrome	0.000718	0.00778	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Zonisamide—epilepsy syndrome	0.000717	0.00777	CcSEcCtD
Icosapent—FABP7—central nervous system—epilepsy syndrome	0.000714	0.00801	CbGeAlD
Icosapent—PPARD—midbrain—epilepsy syndrome	0.000713	0.008	CbGeAlD
Icosapent—Constipation—Amobarbital—epilepsy syndrome	0.000711	0.0077	CcSEcCtD
Icosapent—TRPV1—head—epilepsy syndrome	0.000709	0.00796	CbGeAlD
Icosapent—Alanine aminotransferase increased—Zonisamide—epilepsy syndrome	0.000703	0.00761	CcSEcCtD
Icosapent—FABP7—cerebellum—epilepsy syndrome	0.000698	0.00783	CbGeAlD
Icosapent—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000691	0.00749	CcSEcCtD
Icosapent—Eructation—Pregabalin—epilepsy syndrome	0.000684	0.00741	CcSEcCtD
Icosapent—Malnutrition—Clobazam—epilepsy syndrome	0.000684	0.00741	CcSEcCtD
Icosapent—TRPV1—nervous system—epilepsy syndrome	0.000673	0.00755	CbGeAlD
Icosapent—Arthralgia—Phenobarbital—epilepsy syndrome	0.000651	0.00705	CcSEcCtD
Icosapent—TRPV1—central nervous system—epilepsy syndrome	0.000647	0.00726	CbGeAlD
Icosapent—PTGS1—ganglion—epilepsy syndrome	0.000645	0.00724	CbGeAlD
Icosapent—ACSL4—head—epilepsy syndrome	0.000644	0.00723	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Lamotrigine—epilepsy syndrome	0.000634	0.00687	CcSEcCtD
Icosapent—FADS1—cerebellum—epilepsy syndrome	0.000633	0.0071	CbGeAlD
Icosapent—Eructation—Gabapentin—epilepsy syndrome	0.000627	0.0068	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Lamotrigine—epilepsy syndrome	0.000621	0.00672	CcSEcCtD
Icosapent—PPARD—head—epilepsy syndrome	0.000618	0.00694	CbGeAlD
Icosapent—ACSL4—nervous system—epilepsy syndrome	0.000611	0.00685	CbGeAlD
Icosapent—Dysgeusia—Acetazolamide—epilepsy syndrome	0.000597	0.00647	CcSEcCtD
Icosapent—ACSL4—central nervous system—epilepsy syndrome	0.000588	0.0066	CbGeAlD
Icosapent—PPARD—nervous system—epilepsy syndrome	0.000586	0.00658	CbGeAlD
Icosapent—ACSL4—cerebellum—epilepsy syndrome	0.000575	0.00645	CbGeAlD
Icosapent—Musculoskeletal discomfort—Phenobarbital—epilepsy syndrome	0.000568	0.00616	CcSEcCtD
Icosapent—FABP7—brain—epilepsy syndrome	0.000567	0.00636	CbGeAlD
Icosapent—PPARD—central nervous system—epilepsy syndrome	0.000564	0.00633	CbGeAlD
Icosapent—Dysgeusia—Propofol—epilepsy syndrome	0.000554	0.00601	CcSEcCtD
Icosapent—PPARD—cerebellum—epilepsy syndrome	0.000552	0.00619	CbGeAlD
Icosapent—Malnutrition—Levetiracetam—epilepsy syndrome	0.000547	0.00593	CcSEcCtD
Icosapent—Dyspepsia—Rufinamide—epilepsy syndrome	0.000539	0.00584	CcSEcCtD
Icosapent—Constipation—Phenobarbital—epilepsy syndrome	0.000533	0.00578	CcSEcCtD
Icosapent—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000529	0.00573	CcSEcCtD
Icosapent—Vomiting—Amobarbital—epilepsy syndrome	0.000528	0.00573	CcSEcCtD
Icosapent—Rash—Amobarbital—epilepsy syndrome	0.000524	0.00568	CcSEcCtD
Icosapent—Constipation—Rufinamide—epilepsy syndrome	0.000524	0.00567	CcSEcCtD
Icosapent—Dermatitis—Amobarbital—epilepsy syndrome	0.000523	0.00567	CcSEcCtD
Icosapent—Dysgeusia—Fosphenytoin—epilepsy syndrome	0.000517	0.0056	CcSEcCtD
Icosapent—Malnutrition—Vigabatrin—epilepsy syndrome	0.000514	0.00557	CcSEcCtD
Icosapent—FADS1—brain—epilepsy syndrome	0.000514	0.00577	CbGeAlD
Icosapent—TRPV1—brain—epilepsy syndrome	0.000514	0.00577	CbGeAlD
Icosapent—Vomiting—Primidone—epilepsy syndrome	0.000509	0.00552	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Clobazam—epilepsy syndrome	0.000508	0.00551	CcSEcCtD
Icosapent—Malnutrition—Diazepam—epilepsy syndrome	0.000506	0.00549	CcSEcCtD
Icosapent—PPARG—forebrain—epilepsy syndrome	0.000506	0.00568	CbGeAlD
Icosapent—Dyspepsia—Lacosamide—epilepsy syndrome	0.000506	0.00548	CcSEcCtD
Icosapent—Rash—Primidone—epilepsy syndrome	0.000505	0.00547	CcSEcCtD
Icosapent—Dermatitis—Primidone—epilepsy syndrome	0.000504	0.00546	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Valproic Acid—epilepsy syndrome	0.000503	0.00546	CcSEcCtD
Icosapent—Pruritus—Trimethadione—epilepsy syndrome	0.000498	0.0054	CcSEcCtD
Icosapent—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000497	0.00539	CcSEcCtD
Icosapent—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000496	0.00538	CcSEcCtD
Icosapent—Dysgeusia—Diazepam—epilepsy syndrome	0.000496	0.00537	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Valproic Acid—epilepsy syndrome	0.000493	0.00534	CcSEcCtD
Icosapent—Constipation—Lacosamide—epilepsy syndrome	0.000492	0.00533	CcSEcCtD
Icosapent—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000482	0.00522	CcSEcCtD
Icosapent—Dysgeusia—Felbamate—epilepsy syndrome	0.00048	0.0052	CcSEcCtD
Icosapent—Malnutrition—Zonisamide—epilepsy syndrome	0.00048	0.0052	CcSEcCtD
Icosapent—Constipation—Clobazam—epilepsy syndrome	0.000477	0.00517	CcSEcCtD
Icosapent—Dysgeusia—Zonisamide—epilepsy syndrome	0.00047	0.00509	CcSEcCtD
Icosapent—ACSL4—brain—epilepsy syndrome	0.000467	0.00524	CbGeAlD
Icosapent—Arthralgia—Levetiracetam—epilepsy syndrome	0.000466	0.00504	CcSEcCtD
Icosapent—Malnutrition—Clonazepam—epilepsy syndrome	0.000462	0.00501	CcSEcCtD
Icosapent—Anaphylactic shock—Propofol—epilepsy syndrome	0.000462	0.00501	CcSEcCtD
Icosapent—Malnutrition—Oxcarbazepine—epilepsy syndrome	0.000457	0.00495	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Pregabalin—epilepsy syndrome	0.000455	0.00493	CcSEcCtD
Icosapent—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000452	0.0049	CcSEcCtD
Icosapent—Dysgeusia—Phenytoin—epilepsy syndrome	0.00045	0.00487	CcSEcCtD
Icosapent—Arthralgia—Fosphenytoin—epilepsy syndrome	0.000449	0.00487	CcSEcCtD
Icosapent—PPARD—brain—epilepsy syndrome	0.000448	0.00503	CbGeAlD
Icosapent—Vomiting—Trimethadione—epilepsy syndrome	0.000448	0.00485	CcSEcCtD
Icosapent—Dysgeusia—Oxcarbazepine—epilepsy syndrome	0.000447	0.00485	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Pregabalin—epilepsy syndrome	0.000446	0.00483	CcSEcCtD
Icosapent—Rash—Trimethadione—epilepsy syndrome	0.000444	0.00481	CcSEcCtD
Icosapent—Dermatitis—Trimethadione—epilepsy syndrome	0.000444	0.00481	CcSEcCtD
Icosapent—Malnutrition—Carbamazepine—epilepsy syndrome	0.000438	0.00475	CcSEcCtD
Icosapent—Arthralgia—Vigabatrin—epilepsy syndrome	0.000438	0.00475	CcSEcCtD
Icosapent—Dyspepsia—Acetazolamide—epilepsy syndrome	0.000438	0.00474	CcSEcCtD
Icosapent—Pruritus—Rufinamide—epilepsy syndrome	0.000433	0.00469	CcSEcCtD
Icosapent—Arthralgia—Diazepam—epilepsy syndrome	0.000431	0.00467	CcSEcCtD
Icosapent—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000431	0.00467	CcSEcCtD
Icosapent—Dysgeusia—Carbamazepine—epilepsy syndrome	0.000429	0.00465	CcSEcCtD
Icosapent—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000429	0.00465	CcSEcCtD
Icosapent—Malnutrition—Lamotrigine—epilepsy syndrome	0.000424	0.00459	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Propofol—epilepsy syndrome	0.000421	0.00456	CcSEcCtD
Icosapent—Arthralgia—Felbamate—epilepsy syndrome	0.000417	0.00452	CcSEcCtD
Icosapent—Dysgeusia—Lamotrigine—epilepsy syndrome	0.000415	0.0045	CcSEcCtD
Icosapent—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000413	0.00448	CcSEcCtD
Icosapent—Arthralgia—Zonisamide—epilepsy syndrome	0.000408	0.00443	CcSEcCtD
Icosapent—Pruritus—Lacosamide—epilepsy syndrome	0.000407	0.00441	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Levetiracetam—epilepsy syndrome	0.000407	0.00441	CcSEcCtD
Icosapent—Anaphylactic shock—Felbamate—epilepsy syndrome	0.0004	0.00433	CcSEcCtD
Icosapent—Dyspepsia—Midazolam—epilepsy syndrome	0.000398	0.00431	CcSEcCtD
Icosapent—Vomiting—Phenobarbital—epilepsy syndrome	0.000397	0.0043	CcSEcCtD
Icosapent—Pruritus—Clobazam—epilepsy syndrome	0.000395	0.00428	CcSEcCtD
Icosapent—Arthralgia—Clonazepam—epilepsy syndrome	0.000394	0.00427	CcSEcCtD
Icosapent—Rash—Phenobarbital—epilepsy syndrome	0.000393	0.00426	CcSEcCtD
Icosapent—Dermatitis—Phenobarbital—epilepsy syndrome	0.000393	0.00426	CcSEcCtD
Icosapent—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000393	0.00426	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fosphenytoin—epilepsy syndrome	0.000392	0.00425	CcSEcCtD
Icosapent—Arthralgia—Phenytoin—epilepsy syndrome	0.000391	0.00424	CcSEcCtD
Icosapent—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.00039	0.00423	CcSEcCtD
Icosapent—Vomiting—Rufinamide—epilepsy syndrome	0.000389	0.00422	CcSEcCtD
Icosapent—Arthralgia—Oxcarbazepine—epilepsy syndrome	0.000389	0.00421	CcSEcCtD
Icosapent—Constipation—Midazolam—epilepsy syndrome	0.000386	0.00419	CcSEcCtD
Icosapent—Rash—Rufinamide—epilepsy syndrome	0.000386	0.00418	CcSEcCtD
Icosapent—Dermatitis—Rufinamide—epilepsy syndrome	0.000386	0.00418	CcSEcCtD
Icosapent—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000385	0.00417	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000382	0.00414	CcSEcCtD
Icosapent—Constipation—Levetiracetam—epilepsy syndrome	0.000382	0.00414	CcSEcCtD
Icosapent—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000379	0.00411	CcSEcCtD
Icosapent—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000377	0.00409	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000377	0.00408	CcSEcCtD
Icosapent—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000375	0.00406	CcSEcCtD
Icosapent—Arthralgia—Carbamazepine—epilepsy syndrome	0.000373	0.00404	CcSEcCtD
Icosapent—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000373	0.00404	CcSEcCtD
Icosapent—Dyspepsia—Vigabatrin—epilepsy syndrome	0.00037	0.004	CcSEcCtD
Icosapent—Constipation—Fosphenytoin—epilepsy syndrome	0.000368	0.00399	CcSEcCtD
Icosapent—Vomiting—Lacosamide—epilepsy syndrome	0.000366	0.00396	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000364	0.00395	CcSEcCtD
Icosapent—Dyspepsia—Diazepam—epilepsy syndrome	0.000364	0.00394	CcSEcCtD
Icosapent—Rash—Lacosamide—epilepsy syndrome	0.000362	0.00393	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000362	0.00393	CcSEcCtD
Icosapent—Dermatitis—Lacosamide—epilepsy syndrome	0.000362	0.00392	CcSEcCtD
Icosapent—Arthralgia—Lamotrigine—epilepsy syndrome	0.000361	0.00391	CcSEcCtD
Icosapent—Constipation—Vigabatrin—epilepsy syndrome	0.000359	0.00389	CcSEcCtD
Icosapent—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000358	0.00388	CcSEcCtD
Icosapent—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000357	0.00387	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000357	0.00387	CcSEcCtD
Icosapent—Vomiting—Clobazam—epilepsy syndrome	0.000355	0.00384	CcSEcCtD
Icosapent—Constipation—Diazepam—epilepsy syndrome	0.000353	0.00383	CcSEcCtD
Icosapent—Dyspepsia—Felbamate—epilepsy syndrome	0.000352	0.00382	CcSEcCtD
Icosapent—Rash—Clobazam—epilepsy syndrome	0.000352	0.00381	CcSEcCtD
Icosapent—Dermatitis—Clobazam—epilepsy syndrome	0.000351	0.00381	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Topiramate—epilepsy syndrome	0.000351	0.0038	CcSEcCtD
Icosapent—Dyspepsia—Zonisamide—epilepsy syndrome	0.000345	0.00373	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.000344	0.00373	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000344	0.00373	CcSEcCtD
Icosapent—Constipation—Felbamate—epilepsy syndrome	0.000342	0.00371	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000342	0.0037	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.00034	0.00368	CcSEcCtD
Icosapent—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000338	0.00366	CcSEcCtD
Icosapent—Malnutrition—Valproic Acid—epilepsy syndrome	0.000337	0.00365	CcSEcCtD
Icosapent—Constipation—Zonisamide—epilepsy syndrome	0.000335	0.00363	CcSEcCtD
Icosapent—Dyspepsia—Clonazepam—epilepsy syndrome	0.000332	0.0036	CcSEcCtD
Icosapent—Dyspepsia—Phenytoin—epilepsy syndrome	0.00033	0.00358	CcSEcCtD
Icosapent—Dysgeusia—Valproic Acid—epilepsy syndrome	0.00033	0.00357	CcSEcCtD
Icosapent—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000328	0.00356	CcSEcCtD
Icosapent—Pruritus—Propofol—epilepsy syndrome	0.000327	0.00354	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000326	0.00353	CcSEcCtD
Icosapent—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000326	0.00353	CcSEcCtD
Icosapent—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000324	0.00351	CcSEcCtD
Icosapent—Constipation—Clonazepam—epilepsy syndrome	0.000323	0.0035	CcSEcCtD
Icosapent—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000322	0.00349	CcSEcCtD
Icosapent—Constipation—Phenytoin—epilepsy syndrome	0.000321	0.00347	CcSEcCtD
Icosapent—Pruritus—Midazolam—epilepsy syndrome	0.00032	0.00346	CcSEcCtD
Icosapent—Constipation—Oxcarbazepine—epilepsy syndrome	0.000319	0.00346	CcSEcCtD
Icosapent—Vomiting—Acetazolamide—epilepsy syndrome	0.000316	0.00343	CcSEcCtD
Icosapent—Pruritus—Levetiracetam—epilepsy syndrome	0.000316	0.00342	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000315	0.00341	CcSEcCtD
Icosapent—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000315	0.00341	CcSEcCtD
Icosapent—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000309	0.00335	CcSEcCtD
Icosapent—Constipation—Carbamazepine—epilepsy syndrome	0.000306	0.00332	CcSEcCtD
Icosapent—Pruritus—Fosphenytoin—epilepsy syndrome	0.000305	0.0033	CcSEcCtD
Icosapent—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000304	0.0033	CcSEcCtD
Icosapent—Malnutrition—Pregabalin—epilepsy syndrome	0.000304	0.0033	CcSEcCtD
Icosapent—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000299	0.00324	CcSEcCtD
Icosapent—Dysgeusia—Pregabalin—epilepsy syndrome	0.000298	0.00323	CcSEcCtD
Icosapent—Pruritus—Vigabatrin—epilepsy syndrome	0.000297	0.00322	CcSEcCtD
Icosapent—Constipation—Lamotrigine—epilepsy syndrome	0.000296	0.0032	CcSEcCtD
Icosapent—Vomiting—Propofol—epilepsy syndrome	0.000294	0.00318	CcSEcCtD
Icosapent—Pruritus—Diazepam—epilepsy syndrome	0.000292	0.00317	CcSEcCtD
Icosapent—Rash—Propofol—epilepsy syndrome	0.000291	0.00316	CcSEcCtD
Icosapent—Dermatitis—Propofol—epilepsy syndrome	0.000291	0.00315	CcSEcCtD
Icosapent—PPARG—head—epilepsy syndrome	0.00029	0.00325	CbGeAlD
Icosapent—Vomiting—Midazolam—epilepsy syndrome	0.000287	0.00311	CcSEcCtD
Icosapent—Arthralgia—Valproic Acid—epilepsy syndrome	0.000287	0.00311	CcSEcCtD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—epilepsy syndrome	0.000285	0.0653	CrCbGaD
Icosapent—Rash—Midazolam—epilepsy syndrome	0.000285	0.00309	CcSEcCtD
Icosapent—Dermatitis—Midazolam—epilepsy syndrome	0.000285	0.00308	CcSEcCtD
Icosapent—Vomiting—Levetiracetam—epilepsy syndrome	0.000284	0.00307	CcSEcCtD
Icosapent—Pruritus—Felbamate—epilepsy syndrome	0.000283	0.00307	CcSEcCtD
Icosapent—Rash—Levetiracetam—epilepsy syndrome	0.000281	0.00305	CcSEcCtD
Icosapent—Dermatitis—Levetiracetam—epilepsy syndrome	0.000281	0.00305	CcSEcCtD
Icosapent—Malnutrition—Gabapentin—epilepsy syndrome	0.000279	0.00302	CcSEcCtD
Icosapent—Pruritus—Zonisamide—epilepsy syndrome	0.000277	0.003	CcSEcCtD
Icosapent—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000275	0.00298	CcSEcCtD
Icosapent—PPARG—nervous system—epilepsy syndrome	0.000275	0.00308	CbGeAlD
Icosapent—Vomiting—Fosphenytoin—epilepsy syndrome	0.000274	0.00297	CcSEcCtD
Icosapent—Dysgeusia—Gabapentin—epilepsy syndrome	0.000273	0.00296	CcSEcCtD
Icosapent—Rash—Fosphenytoin—epilepsy syndrome	0.000272	0.00294	CcSEcCtD
Icosapent—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000271	0.00294	CcSEcCtD
Icosapent—PTGS1—forebrain—epilepsy syndrome	0.000271	0.00304	CbGeAlD
Icosapent—Pruritus—Clonazepam—epilepsy syndrome	0.000267	0.00289	CcSEcCtD
Icosapent—Vomiting—Vigabatrin—epilepsy syndrome	0.000267	0.00289	CcSEcCtD
Icosapent—Pruritus—Phenytoin—epilepsy syndrome	0.000265	0.00287	CcSEcCtD
Icosapent—Rash—Vigabatrin—epilepsy syndrome	0.000265	0.00287	CcSEcCtD
Icosapent—PPARG—central nervous system—epilepsy syndrome	0.000265	0.00297	CbGeAlD
Icosapent—Dermatitis—Vigabatrin—epilepsy syndrome	0.000264	0.00287	CcSEcCtD
Icosapent—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000264	0.00286	CcSEcCtD
Icosapent—Vomiting—Diazepam—epilepsy syndrome	0.000263	0.00285	CcSEcCtD
Icosapent—Rash—Diazepam—epilepsy syndrome	0.000261	0.00282	CcSEcCtD
Icosapent—Dermatitis—Diazepam—epilepsy syndrome	0.00026	0.00282	CcSEcCtD
Icosapent—Arthralgia—Pregabalin—epilepsy syndrome	0.000259	0.00281	CcSEcCtD
Icosapent—PTGS2—forebrain—epilepsy syndrome	0.000259	0.0029	CbGeAlD
Icosapent—Vomiting—Felbamate—epilepsy syndrome	0.000254	0.00276	CcSEcCtD
Icosapent—Pruritus—Carbamazepine—epilepsy syndrome	0.000253	0.00274	CcSEcCtD
Icosapent—Rash—Felbamate—epilepsy syndrome	0.000252	0.00273	CcSEcCtD
Icosapent—Dermatitis—Felbamate—epilepsy syndrome	0.000252	0.00273	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.00025	0.00271	CcSEcCtD
Icosapent—Vomiting—Zonisamide—epilepsy syndrome	0.000249	0.0027	CcSEcCtD
Icosapent—PTGS1—telencephalon—epilepsy syndrome	0.000249	0.00279	CbGeAlD
Icosapent—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000248	0.00269	CcSEcCtD
Icosapent—Rash—Zonisamide—epilepsy syndrome	0.000247	0.00268	CcSEcCtD
Icosapent—Dermatitis—Zonisamide—epilepsy syndrome	0.000247	0.00267	CcSEcCtD
Icosapent—Pruritus—Lamotrigine—epilepsy syndrome	0.000245	0.00265	CcSEcCtD
Icosapent—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000242	0.00262	CcSEcCtD
Icosapent—Vomiting—Clonazepam—epilepsy syndrome	0.00024	0.0026	CcSEcCtD
Icosapent—Vomiting—Phenytoin—epilepsy syndrome	0.000238	0.00258	CcSEcCtD
Icosapent—Rash—Clonazepam—epilepsy syndrome	0.000238	0.00258	CcSEcCtD
Icosapent—PTGS2—telencephalon—epilepsy syndrome	0.000238	0.00267	CbGeAlD
Icosapent—Dermatitis—Clonazepam—epilepsy syndrome	0.000238	0.00258	CcSEcCtD
Icosapent—Arthralgia—Gabapentin—epilepsy syndrome	0.000238	0.00258	CcSEcCtD
Icosapent—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000237	0.00257	CcSEcCtD
Icosapent—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000237	0.00257	CcSEcCtD
Icosapent—Rash—Phenytoin—epilepsy syndrome	0.000236	0.00256	CcSEcCtD
Icosapent—Dermatitis—Phenytoin—epilepsy syndrome	0.000236	0.00256	CcSEcCtD
Icosapent—Rash—Oxcarbazepine—epilepsy syndrome	0.000235	0.00255	CcSEcCtD
Icosapent—Constipation—Valproic Acid—epilepsy syndrome	0.000235	0.00255	CcSEcCtD
Icosapent—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000235	0.00255	CcSEcCtD
Icosapent—Malnutrition—Topiramate—epilepsy syndrome	0.000235	0.00254	CcSEcCtD
Icosapent—Dysgeusia—Topiramate—epilepsy syndrome	0.00023	0.00249	CcSEcCtD
Icosapent—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000228	0.00247	CcSEcCtD
Icosapent—Vomiting—Carbamazepine—epilepsy syndrome	0.000228	0.00247	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000226	0.00245	CcSEcCtD
Icosapent—Rash—Carbamazepine—epilepsy syndrome	0.000226	0.00244	CcSEcCtD
Icosapent—Dermatitis—Carbamazepine—epilepsy syndrome	0.000225	0.00244	CcSEcCtD
Icosapent—Vomiting—Lamotrigine—epilepsy syndrome	0.00022	0.00238	CcSEcCtD
Icosapent—Rash—Lamotrigine—epilepsy syndrome	0.000218	0.00236	CcSEcCtD
Icosapent—Dermatitis—Lamotrigine—epilepsy syndrome	0.000218	0.00236	CcSEcCtD
Icosapent—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000214	0.00232	CcSEcCtD
Icosapent—Constipation—Pregabalin—epilepsy syndrome	0.000212	0.0023	CcSEcCtD
Icosapent—PPARG—brain—epilepsy syndrome	0.00021	0.00236	CbGeAlD
Icosapent—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000208	0.00225	CcSEcCtD
Icosapent—Dyspepsia—Gabapentin—epilepsy syndrome	0.000201	0.00217	CcSEcCtD
Icosapent—Arthralgia—Topiramate—epilepsy syndrome	0.0002	0.00217	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000197	0.00213	CcSEcCtD
Icosapent—Constipation—Gabapentin—epilepsy syndrome	0.000195	0.00211	CcSEcCtD
Icosapent—Pruritus—Valproic Acid—epilepsy syndrome	0.000194	0.00211	CcSEcCtD
Icosapent—PTGS2—medulla oblongata—epilepsy syndrome	0.000187	0.0021	CbGeAlD
Icosapent—Pruritus—Pregabalin—epilepsy syndrome	0.000176	0.0019	CcSEcCtD
Icosapent—Vomiting—Valproic Acid—epilepsy syndrome	0.000175	0.00189	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000175	0.00189	CcSEcCtD
Icosapent—PTGS1—spinal cord—epilepsy syndrome	0.000174	0.00196	CbGeAlD
Icosapent—Rash—Valproic Acid—epilepsy syndrome	0.000173	0.00188	CcSEcCtD
Icosapent—Dermatitis—Valproic Acid—epilepsy syndrome	0.000173	0.00188	CcSEcCtD
Icosapent—PTGS2—midbrain—epilepsy syndrome	0.000171	0.00192	CbGeAlD
Icosapent—Dyspepsia—Topiramate—epilepsy syndrome	0.000169	0.00183	CcSEcCtD
Icosapent—PTGS2—spinal cord—epilepsy syndrome	0.000167	0.00187	CbGeAlD
Icosapent—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000165	0.00179	CcSEcCtD
Icosapent—Constipation—Topiramate—epilepsy syndrome	0.000164	0.00178	CcSEcCtD
Icosapent—Pruritus—Gabapentin—epilepsy syndrome	0.000161	0.00175	CcSEcCtD
Icosapent—Vomiting—Pregabalin—epilepsy syndrome	0.000158	0.00171	CcSEcCtD
Icosapent—Rash—Pregabalin—epilepsy syndrome	0.000157	0.0017	CcSEcCtD
Icosapent—Dermatitis—Pregabalin—epilepsy syndrome	0.000156	0.0017	CcSEcCtD
Icosapent—PTGS1—head—epilepsy syndrome	0.000155	0.00174	CbGeAlD
Icosapent—PTGS2—head—epilepsy syndrome	0.000148	0.00166	CbGeAlD
Icosapent—PTGS1—nervous system—epilepsy syndrome	0.000147	0.00165	CbGeAlD
Icosapent—Vomiting—Gabapentin—epilepsy syndrome	0.000145	0.00157	CcSEcCtD
Icosapent—Rash—Gabapentin—epilepsy syndrome	0.000144	0.00156	CcSEcCtD
Icosapent—Dermatitis—Gabapentin—epilepsy syndrome	0.000144	0.00155	CcSEcCtD
Icosapent—PTGS1—central nervous system—epilepsy syndrome	0.000141	0.00159	CbGeAlD
Icosapent—PTGS2—nervous system—epilepsy syndrome	0.00014	0.00158	CbGeAlD
Icosapent—Pruritus—Topiramate—epilepsy syndrome	0.000136	0.00147	CcSEcCtD
Icosapent—PTGS2—central nervous system—epilepsy syndrome	0.000135	0.00152	CbGeAlD
Icosapent—PTGS2—cerebellum—epilepsy syndrome	0.000132	0.00148	CbGeAlD
Icosapent—Vomiting—Topiramate—epilepsy syndrome	0.000122	0.00132	CcSEcCtD
Icosapent—Rash—Topiramate—epilepsy syndrome	0.000121	0.00131	CcSEcCtD
Icosapent—Dermatitis—Topiramate—epilepsy syndrome	0.000121	0.00131	CcSEcCtD
Icosapent—PTGS1—brain—epilepsy syndrome	0.000112	0.00126	CbGeAlD
Icosapent—PTGS2—brain—epilepsy syndrome	0.000107	0.0012	CbGeAlD
Icosapent—PTGS2—Metabolism—GAMT—epilepsy syndrome	1.29e-05	9.29e-05	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—NR3C1—epilepsy syndrome	1.29e-05	9.25e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CACNA1D—epilepsy syndrome	1.29e-05	9.23e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCR5—epilepsy syndrome	1.29e-05	9.23e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—FYN—epilepsy syndrome	1.28e-05	9.21e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—SIRT1—epilepsy syndrome	1.28e-05	9.2e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PFKL—epilepsy syndrome	1.28e-05	9.19e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MEF2C—epilepsy syndrome	1.28e-05	9.16e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PTGS2—epilepsy syndrome	1.27e-05	9.08e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—VDR—epilepsy syndrome	1.26e-05	9.07e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.26e-05	9.03e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—SLC2A1—epilepsy syndrome	1.25e-05	8.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.24e-05	8.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—UPB1—epilepsy syndrome	1.24e-05	8.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ATIC—epilepsy syndrome	1.24e-05	8.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NEU1—epilepsy syndrome	1.24e-05	8.87e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PLCB1—epilepsy syndrome	1.23e-05	8.85e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TH—epilepsy syndrome	1.23e-05	8.82e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ALB—epilepsy syndrome	1.21e-05	8.69e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.21e-05	8.68e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TXNRD1—epilepsy syndrome	1.2e-05	8.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	1.2e-05	8.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—QDPR—epilepsy syndrome	1.2e-05	8.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CA4—epilepsy syndrome	1.2e-05	8.63e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—POMC—epilepsy syndrome	1.2e-05	8.62e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—POMC—epilepsy syndrome	1.2e-05	8.62e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	1.2e-05	8.61e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—H2AFX—epilepsy syndrome	1.2e-05	8.59e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TSC2—epilepsy syndrome	1.2e-05	8.58e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AGT—epilepsy syndrome	1.19e-05	8.57e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	1.19e-05	8.53e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—STX1B—epilepsy syndrome	1.17e-05	8.4e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—APOE—epilepsy syndrome	1.17e-05	8.39e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AQP1—epilepsy syndrome	1.17e-05	8.38e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—YWHAZ—epilepsy syndrome	1.16e-05	8.29e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GBE1—epilepsy syndrome	1.15e-05	8.24e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	1.15e-05	8.24e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KDR—epilepsy syndrome	1.15e-05	8.22e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—NR3C1—epilepsy syndrome	1.14e-05	8.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	1.13e-05	8.14e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COX3—epilepsy syndrome	1.13e-05	8.12e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.12e-05	8.06e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.12e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.1e-05	7.92e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.1e-05	7.92e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.1e-05	7.88e-05	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—AKT1—epilepsy syndrome	1.1e-05	7.87e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ALB—epilepsy syndrome	1.1e-05	7.86e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ALB—epilepsy syndrome	1.1e-05	7.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CPSF4—epilepsy syndrome	1.09e-05	7.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—GBE1—epilepsy syndrome	1.09e-05	7.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPP1R3C—epilepsy syndrome	1.09e-05	7.81e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ASAH1—epilepsy syndrome	1.08e-05	7.75e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—EIF2S1—epilepsy syndrome	1.08e-05	7.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.08e-05	7.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PFKL—epilepsy syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	7.69e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PTGS2—epilepsy syndrome	1.06e-05	7.61e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KDR—epilepsy syndrome	1.06e-05	7.59e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CHRM3—epilepsy syndrome	1.06e-05	7.58e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—KCNJ11—epilepsy syndrome	1.06e-05	7.58e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STXBP1—epilepsy syndrome	1.05e-05	7.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.05e-05	7.52e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.04e-05	7.47e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—HSPB1—epilepsy syndrome	1.04e-05	7.47e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—HMOX1—epilepsy syndrome	1.03e-05	7.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NT5E—epilepsy syndrome	1.02e-05	7.35e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALAD—epilepsy syndrome	1.02e-05	7.35e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6ST—epilepsy syndrome	1.01e-05	7.28e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CAT—epilepsy syndrome	1.01e-05	7.26e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—POMC—epilepsy syndrome	1.01e-05	7.21e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ABCB1—epilepsy syndrome	9.85e-06	7.06e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.84e-06	7.06e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL2—epilepsy syndrome	9.84e-06	7.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ATIC—epilepsy syndrome	9.81e-06	7.04e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UPB1—epilepsy syndrome	9.81e-06	7.04e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NEU1—epilepsy syndrome	9.81e-06	7.04e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	9.77e-06	7.01e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	9.77e-06	7.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	9.76e-06	7e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.64e-06	6.92e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTGS2—epilepsy syndrome	9.59e-06	6.88e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTGS2—epilepsy syndrome	9.59e-06	6.88e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	9.56e-06	6.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	9.44e-06	6.77e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADSL—epilepsy syndrome	9.37e-06	6.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	9.26e-06	6.64e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GLUL—epilepsy syndrome	9.18e-06	6.59e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GPX1—epilepsy syndrome	9.15e-06	6.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GBE1—epilepsy syndrome	9.12e-06	6.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	9.12e-06	6.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ST3GAL3—epilepsy syndrome	9.06e-06	6.5e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	9.02e-06	6.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.91e-06	6.39e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FGF2—epilepsy syndrome	8.89e-06	6.38e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	8.73e-06	6.26e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—JUNB—epilepsy syndrome	8.69e-06	6.24e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCG2—epilepsy syndrome	8.62e-06	6.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ASAH1—epilepsy syndrome	8.58e-06	6.15e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	8.43e-06	6.05e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP2C19—epilepsy syndrome	8.4e-06	6.02e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP11A1—epilepsy syndrome	8.34e-06	5.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STXBP1—epilepsy syndrome	8.34e-06	5.98e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.28e-06	5.94e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RELA—epilepsy syndrome	8.25e-06	5.92e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—FGF2—epilepsy syndrome	8.2e-06	5.88e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AQP1—epilepsy syndrome	8.19e-06	5.87e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.17e-06	5.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NT5E—epilepsy syndrome	8.13e-06	5.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALAD—epilepsy syndrome	8.13e-06	5.83e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MTOR—epilepsy syndrome	8.09e-06	5.8e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AGT—epilepsy syndrome	8.03e-06	5.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.93e-06	5.69e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—APOE—epilepsy syndrome	7.87e-06	5.64e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.86e-06	5.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	7.76e-06	5.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	7.76e-06	5.56e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—RELA—epilepsy syndrome	7.61e-06	5.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	7.59e-06	5.44e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.55e-06	5.42e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP2D6—epilepsy syndrome	7.53e-06	5.4e-05	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.51e-06	5.39e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CASP3—epilepsy syndrome	7.44e-06	5.34e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADSL—epilepsy syndrome	7.44e-06	5.33e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	7.4e-06	5.31e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CHRM3—epilepsy syndrome	7.4e-06	5.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GLUL—epilepsy syndrome	7.29e-06	5.23e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—JUN—epilepsy syndrome	7.23e-06	5.19e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADRA2A—epilepsy syndrome	7.17e-06	5.14e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	7.16e-06	5.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—BCHE—epilepsy syndrome	7.14e-06	5.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.12e-06	5.11e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—epilepsy syndrome	7.03e-06	5.05e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SIRT1—epilepsy syndrome	7e-06	5.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.93e-06	4.97e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—VDR—epilepsy syndrome	6.9e-06	4.95e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.89e-06	4.95e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.82e-06	4.89e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SLC2A1—epilepsy syndrome	6.81e-06	4.89e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—POMC—epilepsy syndrome	6.76e-06	4.85e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.76e-06	4.85e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PLCB1—epilepsy syndrome	6.74e-06	4.83e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TH—epilepsy syndrome	6.71e-06	4.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	6.69e-06	4.8e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.61e-06	4.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EIF2AK2—epilepsy syndrome	6.6e-06	4.73e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—H2AFX—epilepsy syndrome	6.54e-06	4.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AQP1—epilepsy syndrome	6.5e-06	4.66e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—epilepsy syndrome	6.49e-06	4.66e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SRC—epilepsy syndrome	6.48e-06	4.65e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—epilepsy syndrome	6.36e-06	4.56e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—epilepsy syndrome	6.32e-06	4.53e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—YWHAZ—epilepsy syndrome	6.31e-06	4.53e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.24e-06	4.48e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NR3C1—epilepsy syndrome	6.21e-06	4.46e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—epilepsy syndrome	6.16e-06	4.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPIA—epilepsy syndrome	6.11e-06	4.38e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCG2—epilepsy syndrome	6.04e-06	4.33e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SRC—epilepsy syndrome	5.98e-06	4.29e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.94e-06	4.26e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	5.88e-06	4.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CHRM3—epilepsy syndrome	5.88e-06	4.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	5.88e-06	4.22e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	5.85e-06	4.19e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—epilepsy syndrome	5.83e-06	4.18e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.8e-06	4.16e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HMOX1—epilepsy syndrome	5.6e-06	4.02e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CAT—epilepsy syndrome	5.53e-06	3.97e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.47e-06	3.93e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—epilepsy syndrome	5.39e-06	3.87e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCB1—epilepsy syndrome	5.38e-06	3.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.36e-06	3.85e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—epilepsy syndrome	5.33e-06	3.82e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.29e-06	3.8e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	5.28e-06	3.78e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	5.02e-06	3.6e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—BCHE—epilepsy syndrome	5e-06	3.59e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GPX1—epilepsy syndrome	5e-06	3.59e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—epilepsy syndrome	4.99e-06	3.58e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—epilepsy syndrome	4.82e-06	3.46e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—epilepsy syndrome	4.82e-06	3.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCG2—epilepsy syndrome	4.79e-06	3.44e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	4.77e-06	3.42e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PLCB1—epilepsy syndrome	4.72e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TH—epilepsy syndrome	4.7e-06	3.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	4.67e-06	3.35e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	4.64e-06	3.33e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.63e-06	3.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.61e-06	3.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A1—epilepsy syndrome	4.52e-06	3.24e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—JUNB—epilepsy syndrome	4.49e-06	3.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS1—epilepsy syndrome	4.46e-06	3.2e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.42e-06	3.17e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AGT—epilepsy syndrome	4.38e-06	3.14e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOE—epilepsy syndrome	4.29e-06	3.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HBEGF—epilepsy syndrome	4.25e-06	3.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.2e-06	3.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.19e-06	3e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT3—epilepsy syndrome	4.17e-06	2.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ADAM10—epilepsy syndrome	4.08e-06	2.92e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—epilepsy syndrome	4.03e-06	2.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	3.99e-06	2.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—BCHE—epilepsy syndrome	3.97e-06	2.85e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.92e-06	2.82e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CAT—epilepsy syndrome	3.87e-06	2.78e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDC42—epilepsy syndrome	3.81e-06	2.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.79e-06	2.72e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.77e-06	2.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.75e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TH—epilepsy syndrome	3.73e-06	2.68e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—epilepsy syndrome	3.72e-06	2.67e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—POMC—epilepsy syndrome	3.69e-06	2.65e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.5e-06	2.51e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HES1—epilepsy syndrome	3.49e-06	2.5e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—epilepsy syndrome	3.48e-06	2.5e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FYN—epilepsy syndrome	3.39e-06	2.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—H2AFX—epilepsy syndrome	3.38e-06	2.42e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—epilepsy syndrome	3.36e-06	2.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.26e-06	2.34e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CCR5—epilepsy syndrome	3.13e-06	2.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HMOX1—epilepsy syndrome	3.12e-06	2.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CAT—epilepsy syndrome	3.07e-06	2.2e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AGT—epilepsy syndrome	3.07e-06	2.2e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOE—epilepsy syndrome	3.01e-06	2.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.99e-06	2.14e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	2.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TSC2—epilepsy syndrome	2.91e-06	2.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOE—epilepsy syndrome	2.85e-06	2.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.78e-06	1.99e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—epilepsy syndrome	2.71e-06	1.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6ST—epilepsy syndrome	2.68e-06	1.92e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS2—epilepsy syndrome	2.66e-06	1.91e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—POMC—epilepsy syndrome	2.58e-06	1.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AGT—epilepsy syndrome	2.44e-06	1.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOE—epilepsy syndrome	2.39e-06	1.71e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—epilepsy syndrome	2.36e-06	1.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF2—epilepsy syndrome	2.17e-06	1.55e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.06e-06	1.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—POMC—epilepsy syndrome	2.05e-06	1.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTOR—epilepsy syndrome	1.97e-06	1.41e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—epilepsy syndrome	1.9e-06	1.36e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—epilepsy syndrome	1.87e-06	1.34e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—epilepsy syndrome	1.58e-06	1.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—epilepsy syndrome	1.48e-06	1.06e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.04e-06	7.43e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—epilepsy syndrome	9.82e-07	7.05e-06	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—epilepsy syndrome	8.22e-07	5.9e-06	CbGpPWpGaD
